NCT01232296
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Novartis Investigative Site Nanjing, Jiangsu, China
- Novartis Investigative Site Xi’an, Shanxi, China
- Novartis Investigative Site Hangzhou, Zhejiang, China
- Novartis Investigative Site Beijing, China